Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from ...

Gonadotropin hormone receptors, specifically the follicle-stimulating ... and their receptors in regulating antral follicular growth. New hypotheses suggest that receptor-receptor interactions ...

The growth hormone-releasing peptide-6 (GHRP-6) has gained considerable interest in scientific research due to its distinct ...

Its partner hormones are atrial natriuretic peptides ... These include the growth factor receptors, whose overactivations are common features in various cancers. "Our GC-A study should also ...

StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note issued to investors on Monday morning. The brokerage issued a sell rating on the ...

receptor agonists, modern insulins and human insulins. The company is also a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity. NVO is a Zacks Rank #3 ...

StockNews.com assumed coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research report issued to clients and investors on Sunday. The firm set a “sell” rating on ...

Athletes and fitness enthusiasts are always looking for advanced solutions to improve performance, recovery, and muscle growth.